---
title: "Shanghai ZJ Bio-Tech Co., Ltd. (688317.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688317.SH.md"
symbol: "688317.SH"
name: "Shanghai ZJ Bio-Tech Co., Ltd."
industry: "Health Care Supplies"
datetime: "2026-06-10T06:30:05.807Z"
locales:
  - [en](https://longbridge.com/en/quote/688317.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688317.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688317.SH.md)
---

# Shanghai ZJ Bio-Tech Co., Ltd. (688317.SH)

## Company Overview

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | CN Market |
| Website | [www.liferiver.com.cn](https://www.liferiver.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-06-10T04:30:12.000Z

**Overall: D (0.64)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 38 / 40 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -25.98% |  |
| Net Profit YoY | 74.30% |  |
| P/B Ratio | 1.02 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3369991918.31 |  |
| Revenue | 118221886.44 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -1.28% | D |
| Profit Margin | -37.08% | E |
| Gross Margin | 68.86% | A |
| Revenue YoY | -25.98% | E |
| Net Profit YoY | 74.30% | A |
| Total Assets YoY | -1.77% | D |
| Net Assets YoY | -6.49% | D |
| Cash Flow Margin | -139.74% | E |
| OCF YoY | -25.98% | E |
| Turnover | 0.03 | E |
| Gearing Ratio | 10.90% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai ZJ Bio-Tech Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-25.98%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "74.30%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.02",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3369991918.31",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "118221886.44",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-1.28%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-37.08%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "68.86%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-25.98%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "74.30%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "-1.77%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-6.49%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-139.74%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-25.98%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.03",
          "rating": "E"
        },
        {
          "name": "Gearing Ratio",
          "value": "10.90%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -76.88 | 37/40 | - | - | - |
| PB | 1.02 | 4/40 | 1.30 | 1.20 | 1.13 |
| PS (TTM) | 28.51 | 39/40 | 32.40 | 30.57 | 28.94 |
| Dividend Yield | 0.00% | - | 0.56% | 0.46% | 0.43% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Snibe (300832.SZ) | A | D | C | A | C | B |
| 02 | Winner Medical (300888.SZ) | B | B | B | B | B | B |
| 03 | Fuerjia (301371.SZ) | B | C | D | A | B | B |
| 04 | MTM (688029.SH) | B | B | B | A | B | B |
| 05 | Endovastec (688016.SH) | A | B | D | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688317.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688317.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688317.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688317.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**